Tranrilax
Tranrilax Brand names, Tranrilax Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Tranrilax Brand Names Mixture
- No information avaliable
Tranrilax Chemical_Formula
C11H12ClNO3S
Tranrilax RX_link
No information avaliable
Tranrilax fda sheet
Tranrilax msds (material safety sheet)
Tranrilax Synthesis Reference
No information avaliable
Tranrilax Molecular Weight
273.737 g/mol
Tranrilax Melting Point
116.2 oC
Tranrilax H2O Solubility
2500 mg/L (hardly soluble)
Tranrilax State
Solid
Tranrilax LogP
1.208
Tranrilax Dosage Forms
No information avaliable
Tranrilax Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Tranrilax Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Tranrilax Absorption
No information avaliable
Tranrilax side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Tranrilax Patient Information
No information avaliable
Tranrilax Organisms Affected
Humans and other mammals
